Thomas Griffith

Alıntı yapanlar

	Hepsi	2019 yılından bugüne
Alıntılar	23848	6494
h-endeksi	70	38
i10-endeksi	164	121

1300

650

325

975

1996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202474 234 332 570 748 856 826 939 825 954 899 940 802 871 836 902 885 838 803 815 768 713 721 952 1069 1278 1056 1112 1014

Genel erişim

Tümünü görüntüle

92 makale

4 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Thomas FergusonProfessor, ophthalmlogy and Visual sienceswustl.edu üzerinde doğrulanmış e-posta adresine sahip
Vladimir BadovinacDepartment of Pathology, Carver College of Medicine, University of Iowa, Iowa City, IAuiowa.edu üzerinde doğrulanmış e-posta adresine sahip
Salih SanliogluHuman Gene and Cell Therapy Center of Akdeniz University, Antalya, Turkeyakdeniz.edu.tr üzerinde doğrulanmış e-posta adresine sahip
Thomas BrunnerUniversität Konstanzuni-konstanz.de üzerinde doğrulanmış e-posta adresine sahip
David M FergusonProfessor of Medicinal Chemistry University of Minnesotaumn.edu üzerinde doğrulanmış e-posta adresine sahip
Jayanth PanyamUniversity of Minnesotaumn.edu üzerinde doğrulanmış e-posta adresine sahip
John HartyUniversity of Iowauiowa.edu üzerinde doğrulanmış e-posta adresine sahip
William M. NauseefProfessor of Medicine, University of Iowauiowa.edu üzerinde doğrulanmış e-posta adresine sahip
David Masopust PhDUniversity of Minnesotaumn.edu üzerinde doğrulanmış e-posta adresine sahip
Prajwal GurungAssociate Professor at the University of Iowauiowa.edu üzerinde doğrulanmış e-posta adresine sahip
Stephen P. SchoenbergerLa Jolla Institute for Immunologylji.org üzerinde doğrulanmış e-posta adresine sahip
LALIT BEURABrown Universitybrown.edu üzerinde doğrulanmış e-posta adresine sahip
S.C. JamesonUniversity of Minnesotaumn.edu üzerinde doğrulanmış e-posta adresine sahip
Mary M. KavurmaHeart Research Institutehri.org.au üzerinde doğrulanmış e-posta adresine sahip
Badrinath KonetyProfessor, Urology, University of Minnesotaumn.edu üzerinde doğrulanmış e-posta adresine sahip
Gustavo P. Amarante-MendesDepartamento de Imunologia, Instituto de Ciências Biomédicas, Universidade de São Paulousp.br üzerinde doğrulanmış e-posta adresine sahip
Daniel L. MuellerUniversity of Minnesotaumn.edu üzerinde doğrulanmış e-posta adresine sahip
Brian T. FifeUniversity of Minnesotaumn.edu üzerinde doğrulanmış e-posta adresine sahip
Molly IngersollInstitut Pasteurpasteur.fr üzerinde doğrulanmış e-posta adresine sahip
Jesse Warren WilliamsUniversity of Minnesota Medical Schoolumn.edu üzerinde doğrulanmış e-posta adresine sahip

Takip et

Thomas Griffith

University of Minnesota

umn.edu üzerinde doğrulanmış e-posta adresine sahip

immunology sepsis apoptosis inflammation


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo H Walczak, RE Miller, K Ariail, B Gliniak, TS Griffith, M Kubin, W Chin, ... Nature medicine 5 (2), 157-163, 1999	3137	1999
Fas ligand-induced apoptosis as a mechanism of immune privilege TS Griffith, T Brunner, SM Fletcher, DR Green, TA Ferguson Science 270 (5239), 1189-1192, 1995	2743	1995
Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells TS Griffith, WA Chin, GC Jackson, DH Lynch, MZ Kubin The journal of immunology 161 (6), 2833-2840, 1998	902	1998
CD4⁺ T-cell help controls CD8⁺ T-cell memory via TRAIL-mediated activation-induced cell death EM Janssen, NM Droin, EE Lemmens, MJ Pinkoski, SJ Bensinger, ... Nature 434 (7029), 88-93, 2005	843	2005
Intravascular staining for discrimination of vascular and tissue leukocytes KG Anderson, K Mayer-Barber, H Sung, L Beura, BR James, JJ Taylor, ... Nature protocols 9 (1), 209-222, 2014	781	2014
Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade Z Wang, EG Aguilar, JI Luna, C Dunai, LT Khuat, CT Le, A Mirsoian, ... Nature medicine 25 (1), 141-151, 2019	718	2019
TRAIL: a molecule with multiple receptors and control mechanisms TS Griffith, DH Lynch Current opinion in immunology 10 (5), 559-563, 1998	626	1998
Monocyte-mediated tumoricidal activity via the tumor necrosis factor–related cytokine, TRAIL TS Griffith, SR Wiley, MZ Kubin, LM Sedger, CR Maliszewski, NA Fanger The Journal of experimental medicine 189 (8), 1343-1354, 1999	625	1999
Human dendritic cells mediate cellular apoptosis via tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) NA Fanger, CR Maliszewski, K Schooley, TS Griffith The Journal of experimental medicine 190 (8), 1155-1164, 1999	530	1999
CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. PM Stuart, TS Griffith, N Usui, J Pepose, X Yu, TA Ferguson The Journal of clinical investigation 99 (3), 396-402, 1997	481	1997
CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance TS Griffith, X Yu, JM Herndon, DR Green, TA Ferguson Immunity 5 (1), 7-16, 1996	475	1996
Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand M Ehtesham, P Kabos, MAR Gutierrez, NHC Chung, TS Griffith, KL Black, ... Cancer research 62 (24), 7170-7174, 2002	395	2002
The role of FasL-induced apoptosis in immune privilege TS Griffith, TA Ferguson Immunology today 18 (5), 240-244, 1997	349	1997
Functional analysis of TRAIL receptors using monoclonal antibodies TS Griffith, CT Rauch, PJ Smolak, JY Waugh, N Boiani, DH Lynch, ... The Journal of Immunology 162 (5), 2597-2605, 1999	331	1999
Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis Y Gao, JM Herndon, H Zhang, TS Griffith, TA Ferguson The Journal of experimental medicine 188 (5), 887-896, 1998	285	1998
CD8 T cells utilize TRAIL to control influenza virus infection EL Brincks, A Katewa, TA Kucaba, TS Griffith, KL Legge The Journal of Immunology 181 (7), 4918-4925, 2008	281	2008
Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis TS Griffith, RD Anderson, BL Davidson, RD Williams, TL Ratliff The Journal of Immunology 165 (5), 2886-2894, 2000	271	2000
TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies PA Holoch, TS Griffith European journal of pharmacology 625 (1-3), 63-72, 2009	267	2009
Uptake of apoptotic antigen-coupled cells by lymphoid dendritic cells and cross-priming of CD8+ T cells produce active immune unresponsiveness TA Ferguson, J Herndon, B Elzey, TS Griffith, S Schoenberger, DR Green The Journal of Immunology 168 (11), 5589-5595, 2002	240	2002
Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis A Algeciras-Schimnich, TS Griffith, DH Lynch, CV Paya The Journal of Immunology 162 (9), 5205-5211, 1999	223	1999

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar